Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Perez

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|November 25, 2003
Apomine, a novel hypocholesterolemic agent, accelerates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and stimulates low density lipoprotein receptor activityJoseph Roitelman, Danièle Masson, Rachel Avner, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 16, 2010
MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophagesAnne Perez, Matthew B Wright, Cyrille Maugeais, et al.
European Journal of Haematology|August 21, 2024
Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapyEric J Niesor, Anne Perez, Serge Rezzi, et al.
Cardiovascular Drugs and Therapy|March 10, 2015
Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoproteinEric J Niesor, Gregory G Schwartz, Anne Perez, et al.
Digestive Diseases and Sciences|August 18, 2004
The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancerAndrea De Gottardi, Fethi Touri, Christoph A Maurer, et al.
ACS Omega|July 8, 2021
Inhibition of the 3CL Protease and SARS-CoV-2 Replication by DalcetrapibEric J Niesor, Guy Boivin, Eric Rhéaume, et al.
Journal of Lipid Research|May 19, 2017
Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeysMathieu R Brodeur, David Rhainds, Daniel Charpentier, et al.
Journal of Hypertension|May 26, 2010
Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channelsRoger G Clerc, Andrea Stauffer, Franziska Weibel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|November 25, 2003
Apomine, a novel hypocholesterolemic agent, accelerates degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and stimulates low density lipoprotein receptor activityJoseph Roitelman, Danièle Masson, Rachel Avner, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 16, 2010
MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophagesAnne Perez, Matthew B Wright, Cyrille Maugeais, et al.
European Journal of Haematology|August 21, 2024
Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapyEric J Niesor, Anne Perez, Serge Rezzi, et al.
Cardiovascular Drugs and Therapy|March 10, 2015
Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoproteinEric J Niesor, Gregory G Schwartz, Anne Perez, et al.
Digestive Diseases and Sciences|August 18, 2004
The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancerAndrea De Gottardi, Fethi Touri, Christoph A Maurer, et al.
ACS Omega|July 8, 2021
Inhibition of the 3CL Protease and SARS-CoV-2 Replication by DalcetrapibEric J Niesor, Guy Boivin, Eric Rhéaume, et al.
Journal of Lipid Research|May 19, 2017
Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeysMathieu R Brodeur, David Rhainds, Daniel Charpentier, et al.
Journal of Hypertension|May 26, 2010
Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channelsRoger G Clerc, Andrea Stauffer, Franziska Weibel, et al.
Pageof 2